RECRUITING

Strategies to Improve Well-Being and Diabetes Management

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This project aims to implement an adapted self-affirmation intervention among a population of individuals with diabetes to reduce the negative psychosocial impacts of stigma. In a self-affirmation, participants are guiding through a writing exercise writing designed to reinforce sources of self-worth before they encounter or engage in stressful or stigmatizing events. Participants in this study will be asked to complete self-affirmation exercises before their 3-month wellness appointments with their endocrinologists over the course of a year. The main questions the investigators are asking are: * Will self-affirmation reduce feelings of stigmatization? * Will self-affirmation increase self-efficacy and motivation to engage in condition management behaviors. * Will self-affirmation improve blood glucose control. Participants will be randomly assigned to either the intervention condition or a waitlist control condition. Participants in the waitlist control condition will also complete writing exercises but they will be abbreviated (this in the psychological literature is referred to as a "low affirmation condition"). At the end of the study, waitlist control participants will have access to the full exercise should they like to receive it. After each appointment and self-affirmation, participants will complete surveys assessing feelings of stigma and motivation to engage in condition management. All participants will already be using continuous glucose monitors. The investigators will compare both survey responses and continuous glucose data between our conditions to assess the efficacy of the self-affirmation intervention.

Official Title

Strategies to Improve Well-Being and Diabetes Management

Quick Facts

Study Start:2024-07-24
Study Completion:2027-02-28
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06348238

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participants must be at least 18 years of age, have a type 2 diabetes (T2D) diagnosis, and currently use a continue glucose monitor as part of their condition management.
  1. * Individuals under 18 years of age

Contacts and Locations

Study Contact

Elizabeth Scharnetzki
CONTACT
8053409716
elizabeth.scharnetzki@mainehealth.org

Principal Investigator

Elizabeth Scharnetzki
PRINCIPAL_INVESTIGATOR
MaineHealth

Study Locations (Sites)

MaineHealth Institute for Research, Center for Interdisciplinary and Population Health Research
Westbrook, Maine, 04092
United States

Collaborators and Investigators

Sponsor: Elizabeth Scharnetzki

  • Elizabeth Scharnetzki, PRINCIPAL_INVESTIGATOR, MaineHealth

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-24
Study Completion Date2027-02-28

Study Record Updates

Study Start Date2024-07-24
Study Completion Date2027-02-28

Terms related to this study

Additional Relevant MeSH Terms

  • Diabetes Mellitus, Type 2